191 related articles for article (PubMed ID: 30131307)
1. Nasal delivery of nerve growth factor rescue hypogonadism by up-regulating GnRH and testosterone in aging male mice.
Luo J; Yang Y; Zhang T; Su Z; Yu D; Lin Q; Chen H; Zhang Q; Xiang Q; Xue W; Ge R; Huang Y
EBioMedicine; 2018 Sep; 35():295-306. PubMed ID: 30131307
[TBL] [Abstract][Full Text] [Related]
2. NGF Rescues Spermatogenesis in Azoospermic Mice.
Luo J; Yang Y; Ji X; He W; Fan J; Huang Y; Wang Y
Reprod Sci; 2021 Oct; 28(10):2780-2788. PubMed ID: 33725311
[TBL] [Abstract][Full Text] [Related]
3. Deletion of Vax1 from Gonadotropin-Releasing Hormone (GnRH) Neurons Abolishes GnRH Expression and Leads to Hypogonadism and Infertility.
Hoffmann HM; Trang C; Gong P; Kimura I; Pandolfi EC; Mellon PL
J Neurosci; 2016 Mar; 36(12):3506-18. PubMed ID: 27013679
[TBL] [Abstract][Full Text] [Related]
4. Induction of testicular growth and spermatogenesis by pulsatile, intravenous administration of gonadotrophin-releasing hormone in patients with hypogonadotrophic hypogonadism.
Delemarre-Van de Waal HA
Clin Endocrinol (Oxf); 1993 May; 38(5):473-80. PubMed ID: 8330443
[TBL] [Abstract][Full Text] [Related]
5. Oxytocin intranasal administration as a new hope for hypogonadotropic hypogonadism patients.
Salehi MS; Pandamooz S; Khazali H
Med Hypotheses; 2017 Nov; 109():88-89. PubMed ID: 29150303
[TBL] [Abstract][Full Text] [Related]
6. Application of gonadotropin releasing hormone in hypogonadotropic hypogonadism--diagnostic and therapeutic aspects.
Delemarre-van de Waal HA
Eur J Endocrinol; 2004 Nov; 151 Suppl 3():U89-94. PubMed ID: 15554892
[TBL] [Abstract][Full Text] [Related]
7. Changes in anterior pituitary response in patients with idiopathic hypothalamic hypogonadism caused by pulsatile GnRH therapy and testosterone replacement.
Schopohl J; Mojto J; Losa M; Mehltretter G; Müller OA; von Werder K
Exp Clin Endocrinol Diabetes; 1995; 103(3):184-90. PubMed ID: 7584521
[TBL] [Abstract][Full Text] [Related]
8. Defective AMH signaling disrupts GnRH neuron development and function and contributes to hypogonadotropic hypogonadism.
Malone SA; Papadakis GE; Messina A; Mimouni NEH; Trova S; Imbernon M; Allet C; Cimino I; Acierno J; Cassatella D; Xu C; Quinton R; Szinnai G; Pigny P; Alonso-Cotchico L; Masgrau L; Maréchal JD; Prevot V; Pitteloud N; Giacobini P
Elife; 2019 Jul; 8():. PubMed ID: 31291191
[TBL] [Abstract][Full Text] [Related]
9. Normal adults and subjects with hypogonadotropic hypogonadism respond differently to D-Ser(TBU)6-LH-RH-EA10.
Smith R; Donald RA; Espiner EA; Stronach SG; Edwards IA
J Clin Endocrinol Metab; 1979 Jan; 48(1):167-70. PubMed ID: 106067
[TBL] [Abstract][Full Text] [Related]
10. NGF and the Male Reproductive System: Potential Clinical Applications in Infertility.
Ferraguti G; Fanfarillo F; Tarani L; Blaconà G; Tarani F; Barbato C; Minni A; Ralli M; Francati S; Greco A; Petrella C; Fiore M
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361912
[TBL] [Abstract][Full Text] [Related]
11. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
Liu L; Banks SM; Barnes KM; Sherins RJ
J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
[TBL] [Abstract][Full Text] [Related]
12. Pulsatile GnRH treatment in boys and girls with idiopathic hypogonadotrophic hypogonadism.
Delemarre-Van de Waal HA; Odink RJ
Hum Reprod; 1993 Nov; 8 Suppl 2():180-3. PubMed ID: 8276956
[TBL] [Abstract][Full Text] [Related]
13. Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism.
Mao JF; Liu ZX; Nie M; Wang X; Xu HL; Huang BK; Zheng JJ; Min L; Kaiser UB; Wu XY
Asian J Androl; 2017; 19(6):680-685. PubMed ID: 28051040
[TBL] [Abstract][Full Text] [Related]
14. Deletion of Otx2 in GnRH neurons results in a mouse model of hypogonadotropic hypogonadism.
Diaczok D; DiVall S; Matsuo I; Wondisford FE; Wolfe AM; Radovick S
Mol Endocrinol; 2011 May; 25(5):833-46. PubMed ID: 21436260
[TBL] [Abstract][Full Text] [Related]
15. Maintenance of spermatogenesis by intranasal administration of gonadotropin-releasing hormone in patients with hypothalamic hypogonadism.
Klingmüller D; Schweikert HU
J Clin Endocrinol Metab; 1985 Nov; 61(5):868-72. PubMed ID: 3930553
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of leptin receptor and kisspeptin/GPR54 in the murine hypothalamus contributes to male hypogonadism caused by high-fat diet-induced obesity.
Zhai L; Zhao J; Zhu Y; Liu Q; Niu W; Liu C; Wang Y
Endocrine; 2018 Oct; 62(1):195-206. PubMed ID: 29948931
[TBL] [Abstract][Full Text] [Related]
17. The kisspeptin receptor GPR54 is required for sexual differentiation of the brain and behavior.
Kauffman AS; Park JH; McPhie-Lalmansingh AA; Gottsch ML; Bodo C; Hohmann JG; Pavlova MN; Rohde AD; Clifton DK; Steiner RA; Rissman EF
J Neurosci; 2007 Aug; 27(33):8826-35. PubMed ID: 17699664
[TBL] [Abstract][Full Text] [Related]
18. Chronic pulsatile low dose GnRH therapy for induction of testosterone production and spermatogenesis in a man with secondary hypogonadotropic hypogonadism.
Skarin G; Nillius SJ; Wibell L; Wide L
J Clin Endocrinol Metab; 1982 Oct; 55(4):723-6. PubMed ID: 6809782
[TBL] [Abstract][Full Text] [Related]
19. S-Nitrosoglutathione Reductase (GSNOR) Deficiency Results in Secondary Hypogonadism.
Masterson TA; Arora H; Kulandavelu S; Carroll RS; Kaiser UB; Gultekin SH; Hare JM; Ramasamy R
J Sex Med; 2018 May; 15(5):654-661. PubMed ID: 29606625
[TBL] [Abstract][Full Text] [Related]
20. Effect of stage of development and sex on gonadotropin-releasing hormone secretion in in vitro hypothalamic perifusion.
Lacau-Mengido IM; González Iglesias A; Díaz-Torga G; Thyssen-Cano S; Libertun C; Becú-Villalobos D
Proc Soc Exp Biol Med; 1998 Apr; 217(4):445-9. PubMed ID: 9521091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
